Search results for " Stem Cells"

showing 10 items of 881 documents

Dental Pulp Polyps Contain Stem Cells Comparable to the Normal Dental Pulps

2013

Objectives: Few studies investigated the isolation of stem cells from pathologically injured dental tissues. The aim of this study was to assess the possibility of isolation of stem cells from pulp polyps (chronic hyperplastic pulpitis), a pathological tissue produced in an inflammatory proliferative response within a tooth. Study design: Pulp polyp tissues were enzymatically digested and the harvested single cells were cultured. Cultured cells underwent differentiation to adipocytes and osteoblasts as well as flowcytometric analysis for markers such as: CD90, CD73, CD105, CD45, and CD14. In addition we tried to compare other characteristics (including colonigenic efficacy, population doubl…

Pathologymedicine.medical_specialtyOral Medicine and Pathologybusiness.industryResearchMesenchymal stem cellOdontología:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludstomatognathic diseasesmedicine.anatomical_structurestomatognathic systemDental pulp stem cellsUNESCO::CIENCIAS MÉDICASmedicinePulp (tooth)CD90PulpitisBone marrowStem cellbusinessGeneral DentistryPulp polyp
researchProduct

In Vitro Identification and Characterization of CD133pos Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines

2008

BackgroundRecent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown.Methodology/principal findingsATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64+/-9% and 57+/-12%, respectively). These …

Pathologymedicine.medical_specialtySciencemedicine.medical_treatmentThyroid Nuclear Factor 1Cell Culture TechniquesAntineoplastic AgentsCell SeparationStem cell markerDiabetes and Endocrinology/ThyroidSettore MED/13 - EndocrinologiaAntigens CDThyroid peroxidaseCancer stem cellCell Line TumorBiomarkers TumormedicineHumansANAPLASTIC THYROID CARCINOMA CANCER STEM CELLS CD133AC133 AntigenThyroid NeoplasmsGenetics and Genomics/Cancer GeneticsThyroid cancerTumor Stem Cell AssayCell ProliferationGlycoproteinsOncology/Head and Neck CancersMultidisciplinarybiologyCell growthQCarcinomaRNuclear ProteinsTumor Stem Cell Assaymedicine.diseaseFibronectinsembryonic structuresNeoplastic Stem CellsCancer researchbiology.proteinMedicineThyroglobulinStem cellPeptidesTranscription FactorsResearch ArticlePLoS ONE
researchProduct

Identification of progenitor cancer stem cell in lentigo maligna melanoma.

2008

:  The potential role of stem cells in neoplasia has aroused considerable interest over the past few years. A number of known biologic characteristics of melanomas support the theory that they may originate in a mutated stem cell. Melanocytic stem cell markers have been described recently. Moreover, the CD133 cells that show surface markers for CD34 are stem cells primitive. These stem cells are capable of differentiating into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. The identification of cancer stem/initiating cells with a crucial role in tumor formation may open up new pharmacologic perspectives. The purpose of this study is to detect the expression of …

Pathologymedicine.medical_specialtySkin NeoplasmsCD34Antigens CD34DermatologyBiologyStem cell markerHutchinson's Melanotic FreckleCancer stem cellAntigens CDMelanoblastmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansAC133 AntigenLentigo maligna melanomaGlycoproteinsMelanomaGeneral Medicinemedicine.diseasecancer stem cell lentigo maligna melanomaNeoplastic Stem CellsMelanocytesStem cellPeptidesHair FollicleBiomarkersAdult stem cell
researchProduct

Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model.

2015

Objective To study the involvement of seven types of bone marrow-derived cells (BMDCs) in the endometrial regeneration in mice after total body irradiation. Design Prospective experimental animal study. Setting University research laboratories. Animal(s) β-Actin-green fluorescent protein (GFP) transgenic C57BL/6-Tg (CAG-EGFP) and C57BL/6J female mice. Intervention(s) The BMDCs were isolated from CAG-EGFP mice: unfractionated bone marrow cells, hematopoietic progenitor cells, endothelial progenitor cells (EPCs), and mesenchymal stem cells (MSCs). In addition three murine GFP + cell lines were used: mouse Oct4 negative BMDC multipotent adult progenitor cells (mOct4 − BM-MAPCs), BMDC hypoblast…

Pathologymedicine.medical_specialtyStromal cellBone Marrow CellsBiologyEndometriumMicemedicineAnimalsRegenerationProgenitor cellCells CulturedMesenchymal stem cellObstetrics and GynecologyCell DifferentiationMesenchymal Stem CellsTotal body irradiationMolecular biologyBone Marrow-Derived CellTransplantationMice Inbred C57BLmedicine.anatomical_structureReproductive MedicineFemaleBone marrowStem cellWhole-Body IrradiationFertility and sterility
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

Could tubular interstitium be a source of adult epithelial stem cells?

2006

Pathologymedicine.medical_specialtybusiness.industryAmniotic stem cellsstem cellEndothelial stem cellNephrologyMedicineStem cellbusinessRenal stem cellAdult stem cellStem cell transplantation for articular cartilage repairKidney International
researchProduct

Cardiac tissue engineering: a reflection after a decade of hurry

2014

The heart is a perfect machine whose mass is mainly composed of cardiomyocytes, but also fibroblasts, endothelial, smooth muscle, nervous, and immune cells are represented. One thousand million cardiomyocytes are estimated to be lost after myocardial infarction, their loss being responsible for the impairment in heart contractile function (Laflamme and Murry, 2005). The potential success of cardiac cell therapy relies almost completely on the ability of the implanted cells to differentiate toward mature cardiomyocytes. These cells must be able to reinforce the pumping activity of the injured heart in the absence of life-threatening arrhythmias due to electrophysiological incompatibility. Th…

Pathologymedicine.medical_specialtyheart regenerationPhysiologycardiac progenitor cellsClinical uses of mesenchymal stem cellsproto-tissueslcsh:PhysiologyTissue engineeringPhysiology (medical)MedicineInduced pluripotent stem cellStem cell transplantation for articular cartilage repairlcsh:QP1-981business.industryRegeneration (biology)Mesenchymal stem cellOpinion Articletissue engineeringscaffoldsStem cellbusinessNeurosciencecardiac progenitor cells proto-tissues heart regeneration tissue engineering scaffolds biomaterialsbiomaterialsAdult stem cell
researchProduct

Hepatic progenitors for liver disease: current position

2010

Alice Conigliaro1, David A Brenner2, Tatiana Kisseleva21University “La Sapienza”, Dipartimento di Biotecnologie Cellulari ed Ematologia Policlinico Umberto I, V Clinica Medica, Rome, Italy; 2Department of Medicine, University of California, San Diego, La Jolla, CA, USAAbstract: Liver regeneration restores the original functionality of hepatocytes and cholangiocytes in response to injury. It is regulated on several levels, with different cellular populations contributing to this process, eg, hepatocytes, liver precursor cells, intrahepatic stem cells. In response to injury, mature hepatocytes have the capability to proliferate and give rise to new hepatocytes and cholangi…

Pathologymedicine.medical_specialtyoval cellsLiver cytologyMedicine (miscellaneous)cholangiocytes; hepatic progenitor; hepatocytes; intrahepatic stem cells; liver disease; liver precursor cells; oval cellsReviewBiologyhepatocytemedicinecholangiocytesProgenitor cellliver precursor cellQH573-671Mesenchymal stem cellintrahepatic stem cellCell Biologyhepatic progenitorliver precursor cellsintrahepatic stem cellsLiver regenerationCell biologyHaematopoiesisAmniotic epithelial cellsHepatic stellate cellhepatocytesStem cellCytologyliver diseasecholangiocyteStem Cells and Cloning: Advances and Applications
researchProduct

Mesenchymal dental stem cells in regenerative dentistry

2012

In the last decade, tissue engineering is a field that has been suffering an enormous expansion in the regenerative medicine and dentistry. The use of cells as mesenchymal dental stem cells of easy access for dentist and oral surgeon, immunosuppressive properties, high proliferation and capacity to differentiate into odontoblasts, cementoblasts, osteoblasts and other cells implicated in the teeth, suppose a good perspective of future in the clinical dentistry. However, is necessary advance in the known of growth factors and signalling molecules implicated in tooth development and regeneration of different structures of teeth. Furthermore, these cells need a fabulous scaffold that facility t…

Periodontal ligament stem cellsDentistryOdontologíaStem cellsRegenerative MedicineRegenerative medicineRegenerative dentistrystomatognathic systemTissue engineeringDental pulp stem cellsBiomaterials and Bioengineering in DentistryHumansMedicineTissue engineeringGeneral DentistryDental folliclebusiness.industryRegeneration (biology)Mesenchymal stem cellReview-Article:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludCell biologystomatognathic diseasesOtorhinolaryngologyDental stem cellsDentistryUNESCO::CIENCIAS MÉDICASMesenchymal stem cellsSurgeryStem cellbusinessToothMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells

2021

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S2214031X21000656?via%3Dihub Background: Osteoarthritis (OA) is a joint disease characterized by cartilage degradation, low-grade synovitis and subchondral bone alterations. In the damaged joint, there is a progressive increase of oxidative stress leading to disruption of chondrocyte homeostasis. The modulation of oxidative stress could control the expression of inflammatory and catabolic mediators involved in OA. We have previously demonstrated that extracellular vesicles (EVs) present in the secretome of human mesenchymal stem cells from adipose tissu…

Peroxiredoxin 6Adipose tissue-derived mesenchymal stem cellsCélulas madre - Uso terapéutico.Joints - Inflammation - Treatment.Adipose tissueOsteoarthritis - Treatment.InflammationDiseases of the musculoskeletal systemmedicine.disease_causeChondrocyteStem cells - Therapeutic use.ChondrocytesDownregulation and upregulationOsteoarthritismedicineCartilage - Diseases - Treatment.Orthopedics and Sports MedicineCartílagos - Enfermedades - Tratamiento.Osteoartritis - Tratamiento.Estrés oxidativo.ChemistryAutophagyMesenchymal stem cellArticulaciones - Enfermedades - Tratamiento.Joints - Diseases - Treatment.Extracellular vesiclesMicrovesiclesCell biologyOxidative stress.medicine.anatomical_structureRC925-935Oxidative stressOriginal Articlemedicine.symptomArticulaciones - Inflamación - Tratamiento.Oxidative stressJournal of Orthopaedic Translation
researchProduct